Promising Safety and Anti-Lymphoma Efficacy of Autologous Pmb-CT01 (BAFFRCAR T Cell) Therapy in a First-in-Human Phase 1 Study

Category Primary study
JournalBlood
Year 2023
This article has no abstract
Epistemonikos ID: fd5a948a7c731a3b5098f127bbaccfa54ef110f8
First added on: Feb 17, 2025